The undecidedness about nuclear energy is in stark contrast to J. Robert Oppenheimer's Bhagavad Gita-inspired equanimity about his creation...

IPO-bound Paytm, which recently increased its employee stock options pool from around 24 million to around 61 million, has given almost hal...

Automakers and technology firms are investing billions of dollars in autonomous driving, aiming to take an early lead in what many consider...

The US drug agency is bewildered with Indian pharma industry's culture of getting things done at all costs.

Boston and Bengaluru-based Mitra Biotech develops and provides novel technologies that personalise cancer treatment.

"These new funds will allow us to enhance our technology and engage in new studies to further demonstrate CANScript’s clinical utility," sa...

Mylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.

Teva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.

The Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.

'India, receives a drop in the ocean in terms of global liquidity, is not going to get funds just because there is liquidity.'

"We are very bullish on technology per se. Narayana Murthy has come in and has spelt out his strategy. The strategy is to get cost under co...

Serial entrepreneur Kamran Elahian has co-founded 10 firms, of which 6 were successes. But he treasures his “first and biggest” failure the...

Natco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...

India Innovation Fund, best known as the only domestic venture fund that is backed by software services major TCS and telecom leader Airtel...

As blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...